Why this Dallas biotech firm is cutting roughly 35% of its headcount
March 31, 2022 at 18:29 PM EDT
The firm hopes the move will extend Its cash runway to the fourth quarter of 2023.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
